>>GERRY: IT'S TIME NOW FOR THEBUSINESS OF HEALTH...BROUGHT TOYOU BY HENDRICKS REGIONALHEALTH.
AN INDIANA COMPANY IS THE FIRSTIN THE WORLD TO COMMERCIALIZE ADEVICE TO HELP RELIEVE THESYMPTOMS OF OPIOID WITHDRAWAL.
VERSAILLES-BASED INNOVATIVEHEALTH SOLUTIONS SAYS THEINABILITY TO ENDURE WITHDRAWALSYMPTOMS PREVENTS MANY PEOPLE
FROM OVERCOMING OPIOIDADDICTION.AND INSIDE INDIANA BUSINESSREPORTER KYLIE VELETA JOINS US
NOW WITH MORE...>>KYLIE: THANKS, GERRY.INNOVATIVE HEALTH SOLUTIONS SAYSTHE FIRST DAYS OF WITHDRAWAL ARE
SO PAINFUL AND DEBILITATING THATMANY GO BACK TO USING OPIOIDSWITHIN HOURS.THE COMPANY'S DEVICE, THE NSS2
BRIDGE, IS THE FIRST DEVICE FOROPIOID WITHDRAWAL TO EARNED FDAAPPROVAL...THAT HAPPENED JUSTWEEKS AGO.
BRIAN CARRICO, PRESIDENT OFINNOVATIVE HEALTH SOLUTIONS,JOINS ME NOW...THANKS FOR BEINGHERE.
>> THANK YOU FOR HAVING ME.>> TELL US THAT THE BOTH THEDEVICE IN LAYMAN'S TURN HOW DOESIT WORK.
>> IT'S CALLED THE BRIDGE ANDIT'S A NERVE STIMULATOR AND THEDEVICES THE SIZE OF A USB THAT'SPLACED BEHIND SOMEONE'S HERE AND
THERE ARE THREE ELECTRODES THATGO ON THE OF SOMEONE'S HEAD THATPIERCE THE SKIN, THEY BREAK THESKIN.
IT'S NOT PAINFUL AND THEELECTRICAL CURRENT FROM THISTECHNOLOGY ACCESSES THE BRAINAND ESSENTIALLY BLOCKS THE PART
OF THE BRAIN THAT FIRES THESEMISERABLE WITHDRAWAL SYMPTOMS SOA PART OF THE BRAIN THAT CAUSESTHE PAIN, SWEATING, NAUSEA AND
VOMITING AND THIS BRYCE --DEVICE BLOCKS THAT PART OF THEBRAIN TO PREVENT THOSEWITHDRAWAL SYMPTOMS WHEN DELL OF
THE RESEARCH SHOWS THAT85 PERCENT REDUCTION IN THESYMPTOMS IN LESS THAN ONE HOURAND THE DEVICE RUNS FOR FIVE
DAYS, WHICH IS IN MOST INSTANCESIS ENOUGH TIME FOR THE PATIENTTO GET THE OPIOID THAT THEY ARETAKING OUT OF THEIR SYSTEM SO
THEY CAN MOVE ON TO TREATMENTAND RECOVERY.>> THE BIGGEST HURDLE RIGHTNOW IS PATIENTS TRYING TO PAY
FOR IT.$600 OUT-OF-POCKET AND THEN YOUSAID ALSO THE PROCEDURE CAN COSTMONEY ON TOP OF THAT SO IT COULD
BE UP TO $1,200 ALL IN.SO HOW IS YOUR COMPANY TRYING TOHELP OVERCOME THIS HURDLE?>> WE ARE WORKING WITH THE
STATES CURRENTLY AND WE HAVEWORKED WITH THE STATE SINCENOVEMBER 15 WHEN WE GOT THEAPPROVAL AND WE HAVE MULTIPLE
STATES THAT HAVE VERBALLY TOLDUS THEY ARE CLOSE TO APPROVINGTHIS.WE EXPECT SEVERAL STATES TO
COVER THIS IN THE MONTH OFFEBRUARY AND WE HAVE A POLICYTEAM IN PLACE TO WORK WITH EACHSTATE.
ONCE THAT HAPPENS THE STATESWILL HAVE COVERED THISTECHNOLOGY AND THE DOCTORS WILLBE ABLE TO BILL AN EVALUATION
MANAGEMENT CODE AND THE COST CANGO ANYWHERE FROM 700-$1,200DEPENDING ON THE POSITION ANDWHO THEY ARE SAYING AND HOW MUCH
TIME THEY ARE SPENDING.WE ARE WORKING WITH SEVERALDIFFERENT COMMERCIAL INSURANCECARRIERS TO GET THIS COVERED,
BUT IT IS A PROCESS AND TAKESTIME AND WE ARE WORKING WITHTHEM AS WE SPEAK.WE EXPECT COVERAGE TO COME
THROUGH IN MULTIPLE STATES THISMONTH.>> HOW IS IT GOING HERE ININDIANA?
>> WE ARE WORKING WITHINDIANA.WE ARE IN PROCESS.I'M TOLD THE PROCESS IS MOVING
ALONG AS IT DOES.I KNOW IT'S UP 4-6 WEEK PROCESSFOR THEM TO GET THROUGH IT ANDWE SUBMITTED MID TO LATE
DECEMBER'S ON THE NEXT WEEK ORTWO WE GET A MEETING WITHINDIANA TO FIND OUT IF COVERAGEIS ACCEPTED OR IF WE HAVE OTHER
THINGS TO DO WITH THE STATE.>> WE TALKED ABOUT INDIANA ANDTHE RURAL COMMUNITIES SEEM TO BEHIT THE HARDEST, SO GETTING THEM
THROUGH THAT WITHDRAWAL AND ONTOTREATMENT WHAT COULD THAT MEANBIG PICTURE FOR THESECOMMUNITIES?
>> THE MOST IMPORTANT THING ISIT'S AN OUTPATIENT PROCEDURE SOPATIENTS IN RURAL COMMUNITIESCAN GET THIS.
WE ALL KNOW IN THE ADDICTIONWORLD THAT THE BIGGEST HURDLE INTHE CONTINUUM OF CARE ANDADDICTION IS THE WITHDRAWAL.
THERE'S BEEN HELP FOR OTHERPARTS, BUT FOR THE WITHDRAWALPERIOD TO OUR KNOWLEDGE THERE ISNO OTHER APPROVED TECHNOLOGY OR
DRUG FOR THIS.SO IN THE RURAL COMMUNITIES THATALLOW SOMEONE TO GET HELP, GOHOME, COME BACK AND GET
TREATMENT AND THIS ALLOWS PEOPLETO GET BACK TO WORK AND ITALLOWS PEOPLE IN THE JUSTICESYSTEM INSTEAD OF GOING TO JAIL
THEY GET THE BRIDGE ANDTREATMENT AND RECOVERY.>> ALSO WORTH MENTIONING THISIS MANUFACTURED IN
JEFFERSONVILLE AND YOU'REHEADQUARTERED IN VERSE SALES BUTYOU ALSO HAVE A NEW LOCATION INCARMEL.
>> OUR HEADQUARTERS ARE INBURSAE AND MANUFACTURED INJEFFERSONVILLE AND AN OFFICE INCARMEL SO WE ARE IN INDIANA
COMPANY.>> THIS IS THE FIRSTAPPLICATION AND THERE ARE MANYMORE.
>> WE HAVE RESEARCH UNDERWAYIN 10 DIFFERENT DIAGNOSESINCLUDING POSTOP PAIN AT DUKEUNIVERSITY ALONG WITH OTHER
UNIVERSITIES AND WE ARE HOPEFULIN THE NEXT 12-18 MONTHS WE HAVEADDITIONAL INDICATIONS.